文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

新冠肺炎相关急性呼吸窘迫综合征管理与结局的医院间差异

Hospital Variation in Management and Outcomes of Acute Respiratory Distress Syndrome Due to COVID-19.
PubMed 文献 · Crit Care Explor · 2022-02-18
一句话结论在新冠肺炎相关ARDS成人患者中,仅50.4%接受过指南一致性治疗,医院间差异显著,最高使用率 quartile 的院内死亡风险与最低 quartile 无显著差异(OR 0.7,95%CI 0.3-1.9,p=0.49)。

该回顾性观察研究基于重症医学会 Discovery 病毒感染与呼吸疾病通用研究 COVID-19 登记数据库,纳入2020年2月15日至2021年4月12日期间42家医院收治的1,495例新冠肺炎相关ARDS成人患者,评估医院层面指南一致性治疗(低潮气量通气、平台压<30 cm H2O、PaO2/FiO2<100时俯卧位通气)的使用差异。结果显示50.4%患者曾接受指南一致性治疗,校正患者人口学、疾病严重度、医院特征及疫情时段后,收治医院贡献了14%的风险校正变异,较高使用率医院与较低使用率医院相比中位OR为2.0(95%CI 1.1-3.4)。中位校正院内死亡率为53%(IQR 47-62%),最高使用率 quartile 医院死亡率49% vs 最低 quartile 60%,OR 0.7(95%CI 0.3-1.9,p=0.49),无显著差异。作者认为需要提高对推荐ARDS管理策略的依从性。

要点

  • 在42家医院1,495例新冠肺炎相关ARDS成人患者中,仅50.4%曾接受指南一致性治疗(低潮气量通气、平台压<30 cm H2O、PaO2/FiO2<100时俯卧位通气)。
  • 校正患者人口学、疾病严重度、医院特征及疫情时段后,收治医院贡献了14%的指南一致性治疗风险校正变异。
  • 随机选取较高使用率医院与较低使用率医院相比,患者接受指南一致性治疗的中位OR为2.0(95%CI 1.1-3.4)。
  • 中位校正院内死亡率为53%(IQR 47-62%),最高使用率 quartile 医院死亡率49% vs 最低 quartile 60%,OR 0.7(95%CI 0.3-1.9,p=0.49),无显著差异。
  • 作者认为需要采取策略提高对推荐ARDS管理策略的依从性。

适用人群与场景

  • 2020年2月15日至2021年4月12日期间,42家医院收治的1,495例新冠肺炎相关ARDS成人患者。

研究设计与关键结果

  • 研究类型:回顾性观察研究;数据来源:重症医学会 Discovery 病毒感染与呼吸疾病通用研究 COVID-19 登记数据库;样本量:1,495例成人新冠肺炎相关ARDS患者,来自42家医院。
  • 主要结果:50.4%患者曾接受指南一致性治疗(低潮气量通气、平台压<30 cm H2O、PaO2/FiO2<100时俯卧位通气)。
  • 校正患者人口学、疾病严重度、医院特征及疫情时段后,收治医院贡献了14%的指南一致性治疗风险校正变异。
  • 随机选取较高使用率医院与较低使用率医院相比,患者接受指南一致性治疗的中位OR为2.0(95%CI 1.1-3.4)。
  • 中位校正院内死亡率为53%(IQR 47-62%);最高使用率 quartile 医院死亡率49% vs 最低 quartile 60%,OR 0.7(95%CI 0.3-1.9,p=0.49),无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为需要采取策略提高对推荐ARDS管理策略的依从性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To describe hospital variation in use of "guideline-based care" for acute respiratory distress syndrome (ARDS) due to COVID-19.

DESIGN: Retrospective, observational study.

SETTING: The Society of Critical Care Medicine's Discovery Viral Infection and RESPIRATORY ILLNESS UNIVERSAL STUDY COVID-19 REGISTRY.

PATIENTS: Adult patients with ARDS due to COVID-19 between February 15, 2020, and April 12, 2021.

INTERVENTIONS: Hospital-level use of "guideline-based care" for ARDS including low-tidal-volume ventilation, plateau pressure less than 30 cm H2O, and prone ventilation for a Pao2/Fio2 ratio less than 100.

MEASUREMENTS AND MAIN RESULTS: Among 1,495 adults with COVID-19 ARDS receiving care across 42 hospitals, 50.4% ever received care consistent with ARDS clinical practice guidelines. After adjusting for patient demographics and severity of illness, hospital characteristics, and pandemic timing, hospital of admission contributed to 14% of the risk-adjusted variation in "guideline-based care." A patient treated at a randomly selected hospital with higher use of guideline-based care had a median odds ratio of 2.0 (95% CI, 1.1-3.4) for receipt of "guideline-based care" compared with a patient receiving treatment at a randomly selected hospital with low use of recommended therapies. Median-adjusted inhospital mortality was 53% (interquartile range, 47-62%), with a nonsignificantly decreased risk of mortality for patients admitted to hospitals in the highest use "guideline-based care" quartile (49%) compared with the lowest use quartile (60%) (odds ratio, 0.7; 95% CI, 0.3-1.9; p = 0.49).

CONCLUSIONS: During the first year of the COVID-19 pandemic, only half of patients received "guideline-based care" for ARDS management, with wide practice variation across hospitals. Strategies that improve adherence to recommended ARDS management strategies are needed.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Johnson SW, Garcia MA, Sisson EKQ, et al. Hospital Variation in Management and Outcomes of Acute Respiratory Distress Syndrome Due to COVID-19. Crit Care Explor. 2022. PMID: 35211681. doi:10.1097/CCE.0000000000000638

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。